Pentasa

In the US, Pentasa (mesalamine systemic) is a member of the drug class 5-aminosalicylates and is used to treat Crohn's Disease - Maintenance and Ulcerative Colitis - Active.

US matches:

• Pentasa


• Pentasa Controlled-Release Capsules


• Pentasa Rectal

UK matches:

• Pentasa Suppositories 1g
• Pentasa Mesalazine Enema (SPC)
• Pentasa Sachet 1g (SPC)
• Pentasa Sachet 2g (SPC)
• Pentasa Slow Release Tablets 500mg (SPC)
• Pentasa Suppositories 1g (SPC)

Ingredient matches for Pentasa

Mesalazine

Mesalazine is reported as an ingredient of Pentasa in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Canada


• Chile


• China


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Egypt


• Estonia


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Iraq


• Ireland


• Israel


• Italy


• Japan


• Jordan


• Kuwait


• Latvia


• Lebanon


• Lithuania


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Philippines


• Poland


• Portugal


• Qatar


• Saudi Arabia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Syria


• Taiwan


• Thailand


• Tunisia


• United Arab Emirates


• United Kingdom


• United States


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.